Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) treated with omalizumab: results of three randomized, double-blind, placebo-controlled clinical trials

被引:0
|
作者
Spector, S. [1 ]
Antonova, E. [2 ]
Trzaskoma, B. [2 ]
Omachi, T. A. [2 ]
Zazzali, J. L. [2 ]
机构
[1] Calif Allergy & Asthma Med Grp Inc, Los Angeles, CA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
333
引用
收藏
页码:154 / 155
页数:2
相关论文
共 50 条
  • [1] IMPROVEMENT OF SLEEP IN PATIENTS WITH CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) TREATED WITH OMALIZUMAB: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL (GLACIAL)
    Antonova, J.
    Raimundo, K.
    Trzaskoma, B.
    Solari, P.
    Omachi, T.
    Zazzali, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A114 - A115
  • [2] Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
    Gimenez-Arnau, Ana M.
    Spector, Sheldon
    Antonova, Evgeniya
    Trzaskoma, Benjamin
    Rosen, Karin
    Omachi, Theodore A.
    Stull, Donald
    Balp, Maria-Magdalena
    Murphy, Thomas
    CLINICAL AND TRANSLATIONAL ALLERGY, 2016, 6
  • [3] PATTERNS OF RESPONSE IN CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) PATIENTS TREATED WITH OMALIZUMAB IN TWO RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL TRIALS (ASTERIA I AND ASTERIA II).
    Kaplan, A.
    Antonova, E.
    Trzaskoma, B.
    Raimundo, K.
    Khalil, S.
    Omachi, T.
    Zazzali, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A20 - A20
  • [4] Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
    Casale, Thomas
    Maurer, Marcus
    Hsieh, Hsin-Ju
    Canvin, Janice
    Saini, Sarbjit S.
    Grattan, Clive
    Gimenez-Arnau, Ana
    Kaplan, Allen P.
    Rosen, Karin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB327 - AB327
  • [5] Response Patterns in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Patients Treated with Omalizumab for 24 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Clinical Trials (ASTERIA I and GLACIAL)
    Kaplan, Allen P.
    Antonova, Evgeniya
    Trzaskoma, Benjamin
    Raimundo, Karina
    Rosen, Karin
    Omachi, Theodore A.
    Khalil, Sam
    Zazzali, James
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB127 - AB127
  • [6] Correlation between changes in urticaria symptoms and sleep experience in patients with chronic spontaneous/idiopathic urticaria (CSU/CIU): A post-hoc analysis from 2 randomized, double-blind, placebo-controlled phase 3 trials of omalizumab
    Stull, Donald E.
    McBride, Doreen
    Houghton, Katherine
    Balp, Maria-Magdalena
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB43 - AB43
  • [7] Improvement of disease-specific quality of life in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomised, double-blind, placebo-controlled studies
    Maurer, M.
    Raimundo, K.
    Solari, P. G.
    Trzaskoma, B.
    Zazzali, J. L.
    Baiardini, I
    ALLERGY, 2014, 69 : 444 - 444
  • [8] Baseline Characteristics of Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Enrolled in a Phase III, Randomized, Placebo-Controlled Trial of Omalizumab
    Rosen, Karin
    Hsieh, Hsin-Ju
    Georgiou, Panayiotis
    Casale, Thomas
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB29 - AB29
  • [9] Omalizumab normalizes gene expression in lesional skin of patients with chronic idiopathic/spontaneous urticaria: results from a randomized, double-blind, placebo-controlled study
    Metz, M.
    Torene, R.
    Letzkus, M.
    Hartmann, N.
    Staubach, P.
    Bauer, A.
    Brehler, R.
    Gericke, J.
    Ashton-Chess, J.
    Jarvis, P.
    Erpenbeck, V. J.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 19 - 19
  • [10] Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
    Yan, Che-Wen
    Cho, Yung-Tsu
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2017, 35 (04) : 182 - 186